China Pharma Holdings (CPHI) Capital Expenditures Growth (5y) (2015 - 2025)
China Pharma Holdings (CPHI) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | China Pharma Holdings | 41.34 Mn | 41.03 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.89% |
| Sep 30, 2025 | -70.19% |
| Jun 30, 2025 | -14.87% |
| Mar 31, 2025 | -30.03% |
| Dec 31, 2024 | -17.21% |
| Sep 30, 2024 | -22.47% |
| Dec 31, 2023 | -23.96% |
| Sep 30, 2023 | 82.30% |
| Jun 30, 2023 | -16.77% |
| Mar 31, 2023 | -77.12% |
| Dec 31, 2022 | -19.08% |
| Sep 30, 2022 | 74.71% |
| Jun 30, 2022 | 47.41% |
| Mar 31, 2022 | -44.59% |
| Dec 31, 2021 | -41.95% |
| Sep 30, 2021 | 83.24% |
| Dec 31, 2020 | 25.23% |
| Sep 30, 2020 | 41.72% |
| Jun 30, 2020 | 17.74% |
| Mar 31, 2020 | 49.16% |